Viewing Study NCT01996267


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-24 @ 2:07 PM
Study NCT ID: NCT01996267
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-03-29
First Post: 2013-11-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2
Sponsor: The Netherlands Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module